濮阳东方医院男科口碑好收费低濮阳东方男科治病便宜,濮阳东方医院治早泄价格比较低,濮阳东方看男科专业,濮阳东方医院价格非常低,濮阳东方妇科医院做人流手术价格,濮阳东方看男科病技术很专业,濮阳东方妇科医院做人流口碑好收费低

PARIS, May 17 (Xinhua) -- Arianespace has approved the preparation review of the third Ariane 5 flight, which is expected to lift two communication satellites on Friday from the spaceport in French Guiana, the European launching center said on Tuesday.The prior readiness review approved that "Ariane 5 is now cleared for its May 19 rollout from the Final Assembly Building to the ELA-3 launch zone, where it will be readied for liftoff on Friday at 5:38 p.m. local time in French Guiana," the space center said in a statement.This dual payload flight will orbit GSAT-8 and ST-2 satellites, with a combined mass of 8,190 kilo grams.Built by Japan's Mitsubishi Electric Company, ST-2 will be utilized by the ST-2 Satellite Ventures joint company of Singapore Telecommunications Ltd (SingTel) and Taiwan's Chunghwa Telecom Company Ltd. for Ku- and C-band relay services across the Middle East, Central Asia, India and Southeast Asia.The lighter passenger GSAT-8, built by the Indian Space Research Organization (ISRO), will serve to augment India's Ku- band relay capabilities and offer aircraft navigation assistance over Indian airspace and adjoining areas with its two-channel GAGAN system.The Arianespace started its 2011 busy year for heavy-lift Ariane 5 with the milestone launch of Europe's second Automated Transfer Vehicle (ATV) on February 16, and then a dual payload on April 22 that orbited Yahsat Y1A and Intelsat New Dawn satellites.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

WELLINGTON, May 24 (Xinhua) -- New Zealand researchers have found a way to stop the growth of certain cancer tumors by " silencing" a group of PAX genes, members of a small family of genes that play important roles in embryonic development, but also allow cancer cells to grow and divide in adult tissue.In an article published in UK medical journal Oncogene, Otago University Professor Michael Eccles and colleagues revealed how they used the PAX8 gene to kill cancer cells.After detecting high levels of PAX8 protein in the majority of kidney, ovarian and thyroid cancers they studied, the researchers used molecular techniques to silence the PAX8 gene in several cancer cell lines."We found that these PAX8-depleted cancer cells ceased growing and dividing. The cells were essentially stopped in their tracks through the failure of multiple mechanisms and pathways crucial to their cell division cycle. They then entered into a state called senescence in which they no longer divided, and after that they ultimately died," Eccles said in a statement from the university Tuesday.The findings suggested that PAX8 could be a good target for the development of new cancer therapies, he said."Any resulting drugs would be a long way down the road, but in the meantime this research helps confirm that a focus on PAX genes may prove to be a fruitful line of attack against a number of cancers," he said.The research was supported by grants from the Health Research Council of New Zealand. It formed the main piece of work carried out by Otago doctoral graduate Caiyun (Grace) Li, now a postdoctoral fellow at Stanford University. Study co-authors also included Professor Antony Braithwaite and master's student Jen Nyman.In 2003, research led by Eccles discovered that proteins from one or more of the nine PAX genes were present in many common cancers. They found that "silencing" the gene expression of PAX2 in ovarian and bladder cancer cells, and of PAX3 in melanoma, led to the rapid death of the cells.

BEIJING, Feb. 15 (Xinhua) -- China's consumer inflation accelerated in January on surging food prices, adding pressure for the government to tackle escalating inflation amid the nation's spreading winter drought.The consumer price index (CPI), a main gauge of inflation, rose 4.9 percent in January year on year, the National Bureau of Statistics (NBS) announced Tuesday.The figure is 0.3 percentage points higher than that of December.Food prices soared 10.3 percent year on year.

WELLINGTON, May 22 (Xinhua) -- One in every eight women giving birth in a New Zealand hospital last year was Asian, local media reported Sunday.In the country's most populous city, Auckland, 5,149 Asian women gave birth, more than double the number of 15 years ago, the New Zealand Herald reported.Last year was the first year in the city when more Asian women gave birth than indigenous Maori women, who registered 5,015 births.Citing figures from the government statistics agency, Statistics New Zealand, the report said the majority of women nationwide who gave birth last year were still of European descent, accounting for 43,965 of last year's 63,897 births.But more women of other ethnic backgrounds were also becoming mothers, including those from the Middle East, Latin America and Africa.Auckland University head of obstetrics and gynaecology, Professor Lesley McCowan, said the increase reflected New Zealand is an increasingly multicultural society.